BlackRock

BlackRock

BlackRock is tracked through public portfolio filings, disclosed holdings, and institutional investment activity. This BlackRock portfolio page tracks BlackRock holdings, stock picks, latest portfolio moves, and historical 13F filing changes so readers can see which public companies BlackRock owns and how disclosed positions change over time. BlackRock's public portfolio can help investors study position sizing, sector exposure, concentration, new buys, trims, exits, and the market themes behind reported capital allocation decisions. Top disclosed holdings and portfolio changes shown on this page include NVIDIA Corporation (NVDA), Apple Inc (AAPL), Microsoft Corp (MSFT), Alphabet Inc (GOOGL), and Alphabet Cl C (GOOG). Investors use BlackRock 13F filings to study portfolio concentration, new buys, trims, exits, sector exposure, and the market evidence behind the latest disclosed holdings.

Biggest Losses

PositionReported PriceCurrent PriceEst. P/LReturnEst. Value
Chicken Soup for the Soul Entertainment, Inc.CSSEQ · Q2 2024$0.194$0.0001-$7.2k-99.9%$4
Presto Automation, Inc.PRST · Q2 2024$0.0702$0.0001-$134-99.9%$0
Cumulus Media Inc.CMLSQ · Q2 2024$2.04$0.003-$412k-99.9%$607
Enservco CorporationENSV · Q2 2024$0.23$0.0005-$267-99.8%$1
Charles & Colvard, Ltd.CTHRQ · Q2 2024$1.71$0.0056-$10k-99.7%$33
Zynex, Inc.ZYXIQ · Q2 2024$9.32$0.055-$12M-99.4%$68k
iRobot CorporationIRBT · Q2 2024$9.11$0.054-$20M-99.4%$120k
Nine Energy Service, Inc.NINEQ · Q2 2024$1.68$0.012-$688k-99.3%$4.9k
Longevity Health Holdings Inc.XAGEW · Q2 2024$1.33$0.01-$48k-99.2%$363
Adaptimmune Therapeutics plcADAPY · Q2 2024$0.9749$0.0087-$187k-99.1%$1.7k
Carisma Therapeutics, Inc.CARM · Q2 2024$1.52$0.019-$1.1M-98.8%$13k
ProPhase Labs, Inc.PRPH · Q2 2024$4.18$0.08-$264k-98.1%$5.1k
Bio-Path Holdings, Inc.BPTH · Q2 2024$2.00$0.04-$4.7k-98.0%$95
Applied Therapeutics, Inc.APLT · Q2 2024$4.67$0.103-$30M-97.8%$677k
New Fortress Energy Inc.NFE · Q2 2024$21.98$0.58-$84M-97.4%$2.3M
LuxUrban Hotels Inc.LUXH · Q2 2024$0.2343$0.0065-$6.2k-97.2%$178
SRx Health Solutions Inc.SRXH · Q2 2024$3.89$0.1105-$212-97.2%$6
Wag! Group Co.PET · Q2 2024$1.60$0.0469-$83k-97.1%$2.5k
Booking Holdings IncBKNG · Q2 2024$3,961.50$162.30-$9.2B-95.9%$392M
Generation Income Properties, Inc.GIPR · Q2 2024$4.09$0.1726-$80k-95.8%$3.5k
SUPER MICRO COMPUTER INCSMCI · Q2 2024$819.35$38.19-$3.1B-95.3%$153M
Cambium Networks CorporationCMBM · Q2 2024$2.79$0.1301-$696k-95.3%$34k
NKGen Biotech, Inc. Common StockNKGN · Q2 2024$1.27$0.06-$21k-95.3%$1.0k
Vertex Energy, IncVTNR · Q2 2024$0.9447$0.0521-$1.3M-94.5%$79k
Cutera, Inc.CUTR · Q2 2024$1.51$0.0969-$566k-93.6%$39k
Strategy IncMSTR · Q2 2024$1,377.48$94.13-$1.1B-93.2%$83M
Omega Therapeutics, Inc.OMGA · Q2 2024$2.07$0.1426-$701k-93.1%$52k
Equity CommonwealthEQC · Q2 2024$19.40$1.58-$199M-91.9%$18M
O'Reilly Automotive IncORLY · Q2 2024$1,056.06$89.02-$4.0B-91.6%$371M
KinderCare Learning Companies, Inc.KLC · Q2 2024$49.19$4.18-$392M-91.5%$36M
Prairie Operating Co.PROP · Q2 2024$10.85$0.9465-$2.1M-91.3%$196k
CONN'S INCCONN · Q2 2024$1.10$0.0975-$1.3M-91.2%$126k
CXApp Inc.CXAI · Q2 2024$2.02$0.1836-$41k-90.9%$4.1k
Mereo BioPharma Group plcMREO · Q2 2024$3.60$0.3287-$55k-90.9%$5.5k
RxSight, Inc.RXST · Q2 2024$60.17$5.62-$131M-90.7%$13M
Superior Industries International, Inc.SUP · Q2 2024$3.25$0.3249-$1.4M-90.0%$161k
Edgio, Inc.EGIO · Q2 2024$10.92$1.11-$534k-89.8%$60k
Sarepta Therapeutics, Inc.SRPT · Q2 2024$158.00$16.68-$1.5B-89.4%$172M
HAIN CELESTIAL GROUP INCHAIN · Q2 2024$6.91$0.7586-$91M-89.0%$11M
Eagle Pharmaceuticals, Inc.EGRX · Q2 2024$5.60$0.615-$1.8M-89.0%$217k
Tractor Supply CoTSCO · Q2 2024$270.00$30.14-$2.3B-88.8%$284M
Mercer International Inc.MERC · Q2 2024$8.54$0.9613-$36M-88.7%$4.5M
Endava plc American Depositary SharesDAVA · Q2 2024$29.24$3.30-$11M-88.7%$1.3M
Alight, Inc.ALIT · Q2 2024$7.38$0.8703-$215M-88.2%$29M
Deckers Outdoor CorpDECK · Q2 2024$967.95$114.37-$2.2B-88.2%$291M
Filana Therapeutics, Inc.FLNA · Q2 2024$12.35$1.50-$35M-87.9%$4.8M
Cibus, Inc.CBUS · Q2 2024$9.85$1.20-$8.5M-87.8%$1.2M
Netflix IncNFLX · Q2 2024$674.88$82.64-$19B-87.8%$2.6B
Azul S.A.AZUL · Q2 2024$4.00$0.50-$956k-87.5%$137k
Rocket Pharmaceuticals, Inc.RCKT · Q2 2024$21.53$2.70-$117M-87.5%$17M
BlackRock Biggest Losses | TradingNote